Literature DB >> 19799615

Influence of smoking abstinence and nicotine replacement therapy on heart rate and QT time-series.

M J Lewis1, G Balaji, H Dixon, Y Syed, K E Lewis.   

Abstract

SUMMARY: Many smokers attempt to quit without using nicotine replacement therapy (NRT) or pharmacotherapy, i.e. 'cold-turkey'. The cardiac implications of this are important but are incompletely understood. Previous studies have associated smoking cessation with improvements in heart rate (HR) and its variability, but its influence on QT time-series is unclear. Furthermore, the relative influence on these parameters of acute nicotine withdrawal and of NRT has not been adequately compared. Additional insight might come from analysing the dynamic (e.g. fractal) properties of electrocardiographic data during different levels of nicotine exposure. We examined the influence of smoking cessation, during cold-turkey and subsequent NRT, on HR and QT time-series during 30 days of smoking abstinence. Seven smokers and sixteen healthy non-smokers received ECG monitoring at baseline (Day 0). Smokers subsequently refrained from smoking without using NRT for 24 h, and then received NRT for 29 days. ECG monitoring was repeated at Days 1, 7, 30. Following smoking cessation we observed that: HR and rate-corrected QT were both reduced, heart rate variability (HRV) increased (improved), and QT variability index (QTVI) showed signs of improvement (trend only). Improvements in HR and QT were maintained throughout NRT use, whilst improvements in HRV and QTVI were sustained for at least the early stages of NRT. The dynamic (multifractal) properties of HR and QT were similar for smokers and non-smokers, and were unchanged by smoking abstinence or NRT. Our results provide tentative evidence that electrocardiographic improvements during a cold-turkey smoking quit attempt (acute nicotine withdrawal) are maintained during NRT pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799615     DOI: 10.1111/j.1475-097X.2009.00902.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  6 in total

1.  Blunted vagal reactivity predicts stress-precipitated tobacco smoking.

Authors:  Rebecca L Ashare; Rajita Sinha; Rachel Lampert; Andrea H Weinberger; George M Anderson; Meaghan E Lavery; Katherine Yanagisawa; Sherry A McKee
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

2.  Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women.

Authors:  Tellervo Korhonen; Amy Goodwin; Petra Miesmaa; Elizabeth A Dupuis; Taru Kinnunen
Journal:  J Womens Health (Larchmt)       Date:  2011-06-15       Impact factor: 2.681

3.  Smoking's effects on respiratory sinus arrhythmia in adolescent smokers.

Authors:  Megan Conrad; Stephanie M Gorka; Jon Kassel
Journal:  Int J Psychophysiol       Date:  2015-05-07       Impact factor: 2.997

Review 4.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

5.  Coffee, alcohol, smoking, physical activity and QT interval duration: results from the Third National Health and Nutrition Examination Survey.

Authors:  Yiyi Zhang; Wendy S Post; Darshan Dalal; Elena Blasco-Colmenares; Gordon F Tomaselli; Eliseo Guallar
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

6.  Potential side effects of unhealthy lifestyle choices and health risks on basal and reactive heart rate variability in college drinkers.

Authors:  Tomoko Udo; Eun-Young Mun; Jennifer F Buckman; Evgeny G Vaschillo; Bronya Vaschillo; Marsha E Bates
Journal:  J Stud Alcohol Drugs       Date:  2013-09       Impact factor: 3.346

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.